Juniper Pharmaceuticals (JNP) Form 3 JUNIPER PHARMACEUTICALS / RICHARD MESSINA ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

MESSINA RICHARD

(Last) (First) (Middle)

C/O JUNIPER PHARMACEUTICALS INC.

33 ARCH STREET SUITE 3110

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2018

3. Issuer Name and Ticker or Trading Symbol
JUNIPER PHARMACEUTICALS INC [ JNP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,032	D
Common Stock	250	I	See Footnote(1)
Common Stock	250	I	See Footnote(2)
Common Stock	250	I	See Footnote(3)
Common Stock	8,000	I	See Footnote(4)
Common Stock	9,700	I	See Footnote(5)
Common Stock	41,000	I	See Footnote(6)
Common Stock	14,500	I	See Footnote(7)
Common Stock	2,001	I	See Footnote(8)
Common Stock	28,000	I	See Footnote(9)
Common Stock	6,250	I	See Footnote(10)
Common Stock	875	I	See Footnote(11)
Common Stock	100,000	I	See Footnote(12)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. shares held by Richard Messina CF Jacqueline Messina UTMA

2. shares held by Richard Messina CF Carolyn Messina UTMA

3. shares held by Richard Messina CF Madeline Messina UTMA

4. Shares held by Equity TR Co TTEE FBO Pamela Brocious SEP

5. Shares held by Steve A. Sanders and Partners

6. Shares held by Citistaffing LLC Profit Sharing

7. Shares held by Summit Capital Associates.

8. Shares held by Benchmark Pellinore Group

9. Shares held by SCA Retirement Plan DTD 1/1/91

10. Shares held by Pamela Brocious M/P PEN PL

11. Shares held by SCA Money Purchase Plan DTD 1/1/94 Attn Richard Messina

12. Shares held by The Benchmark Company LLC - Investment Purposes

Remarks:

	/s/ Jeffrey Young, Attorney-in-Fact	03/22/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.